114 related articles for article (PubMed ID: 776394)
1. Precursor lesions for liver cancer in humans.
Anthony PP
Cancer Res; 1976 Jul; 36(7 PT 2):2579-83. PubMed ID: 776394
[TBL] [Abstract][Full Text] [Related]
2. Precancerous changes in the human liver.
Anthony PP
J Toxicol Environ Health; 1979; 5(2-3):301-13. PubMed ID: 224200
[TBL] [Abstract][Full Text] [Related]
3. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.
Kuper H; Ye W; Broomé U; Romelsjö A; Mucci LA; Ekbom A; Adami HO; Trichopoulos D; Nyrén O
Hepatology; 2001 Oct; 34(4 Pt 1):714-8. PubMed ID: 11584367
[TBL] [Abstract][Full Text] [Related]
4. Liver cell dysplasia: a premalignant condition.
Anthony PP; Vogel CL; Barker LF
J Clin Pathol; 1973 Mar; 26(3):217-23. PubMed ID: 4700503
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.
Serfaty L; Chazouillères O; Poujol-Robert A; Morand-Joubert L; Dubois C; Chrétien Y; Poupon RE; Petit JC; Poupon R
Hepatology; 1997 Sep; 26(3):776-9. PubMed ID: 9303512
[TBL] [Abstract][Full Text] [Related]
6. Preneoplastic conditions of the liver.
Riegler JL
Semin Gastrointest Dis; 1996 Apr; 7(2):74-87. PubMed ID: 8705261
[TBL] [Abstract][Full Text] [Related]
7. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
8. Liver-cell dysplasia and hepatocellular carcinoma.
Podda M; Roncalli M; Battezzati PM; Borzio M; Bruno S; Servida E; Coggi G
Ital J Gastroenterol; 1992 Jan; 24(1):39-42. PubMed ID: 1315175
[TBL] [Abstract][Full Text] [Related]
9. [Liver cancer in the Chinese].
Wellmann KF; Gerstmann KE
Dtsch Med Wochenschr; 1979 Jun; 104(26):949-54. PubMed ID: 378629
[No Abstract] [Full Text] [Related]
10. Medical history and primary liver cancer.
La Vecchia C; Negri E; D'Avanzo B; Boyle P; Franceschi S
Cancer Res; 1990 Oct; 50(19):6274-7. PubMed ID: 2400990
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
12. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
13. Primary liver carcinoma in Israel.
Costin C; Steinitz R
Isr J Med Sci; 1971 Dec; 7(12):1471-4. PubMed ID: 4335648
[No Abstract] [Full Text] [Related]
14. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
Lefkowitch JH; Apfelbaum TF
Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
[TBL] [Abstract][Full Text] [Related]
15. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
Cohen C; Derose PB
Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis C in tropical areas].
Debonne JM; Nicand E; Boutin JP; Carre D; Buisson Y
Med Trop (Mars); 1999; 59(4 Pt 2):508-16. PubMed ID: 10901856
[TBL] [Abstract][Full Text] [Related]
17. Independent risk factors for hepatocellular carcinoma in French drinkers.
Poynard T; Aubert A; Lazizi Y; Bedossa P; Hamelin B; Terris B; Naveau S; Dubreuil P; Pillot J; Chaput JC
Hepatology; 1991 May; 13(5):896-901. PubMed ID: 1851493
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology of hepatocellular carcinoma].
Ricca Rosellini S; Miglio F
Minerva Gastroenterol Dietol; 1991; 37(2):73-84. PubMed ID: 1660311
[TBL] [Abstract][Full Text] [Related]
19. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.
Xu J; Shi J; Wang YP; Lin Y; Chen YX; Lu J; Zeng X; Xie WF
Med Sci Monit; 2009 Jun; 15(6):CR274-9. PubMed ID: 19478697
[TBL] [Abstract][Full Text] [Related]
20. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
